Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Weight-loss drugs linked to dramatically lower death rates in colon cancer patients - GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the ...

Colorectal cancer is striking younger adults at alarming rates, driven by lifestyle and genetic factors. Colorectal cancer (CRC) develops when abnormal cells grow uncontrollably in the colon or rectum ...